SG Americas Securities’s KalVista Pharmaceuticals KALV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $507K | Buy |
|
|||||
|
2025
Q1 | – | Sell |
|
|||||
|
2024
Q4 | $123K | Buy |
|
|||||
|
2024
Q3 | $153K | Buy |
|
|||||
|
2024
Q2 | – | Sell |
|
|||||
|
2024
Q1 | $143K | Sell |
|
|||||
|
2023
Q4 | $1.69M | Buy |
|
|||||
|
2023
Q3 | $1.26M | Buy |
|
|||||
|
2023
Q2 | $1.09M | Buy |
|
|||||
|
2023
Q1 | – | Sell |
|
|||||
|
2022
Q4 | $106K | Sell |
|
|||||
|
2022
Q3 | $240K | Sell |
|
|||||
|
2022
Q2 | $164K | Buy |
|
|||||
|
2022
Q1 | – | Sell |
|
|||||
|
2021
Q4 | $158K | Sell |
|
|||||
|
2021
Q3 | $314K | Sell |
|
|||||
|
2021
Q2 | $553K | Buy |
|
|||||
|
2021
Q1 | $576K | Buy |
|
|||||
|
2020
Q4 | $104K | Buy |
|
|||||
|
2016
Q1 | – | Sell |
|
|||||
|
2015
Q4 | $44K | Sell |
|
|||||
|
2015
Q3 | $66K | Buy |
|